相关实验视频
Updated: May 4, 2026

08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
8.5K
对冠状动脉心脏病中的m6A甲基化进行了全面的审查
Mei-Ning Diao1,2, Yi-Jv Lv1,2, Hui Xin1
1Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, Shandong, P. R. China.
概括
m6A甲基化,一种RNA修饰,在冠心病 (CHD) 的发展中起着关键作用. 准m6A调节器为早期CHD检测和新的治疗策略提供了一个有希望的途径.
科学领域:
- 生物化学 生化学
- 心血管生物学 心血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 冠状动脉心脏病 (CHD) 构成了全球重大健康负担,主要是由冠状动脉样硬化 (AS) 驱动的.
- 冠状动脉炎症涉及慢性炎症和冠状动脉血管内的细胞变化.
- 像m6A甲基化这样的RNA修饰正在成为疾病发病的关键因素.
研究的目的:
- 调查m6A甲基化在冠心病 (CHD) 的发展和进展中的作用.
- 探索m6A调节器作为CHD的诊断标记物和治疗点的潜力.
主要方法:
- 在动脉样硬化和心血管疾病的背景下,对m6A甲基化及其调节物的当前研究进行审查.
- 分析m6A修饰如何影响心血管疾病的关键病理过程,包括炎症,细胞死亡和纤维化.
主要成果:
- m6A甲基化调节剂涉及AS的发病,影响炎症反应和细胞增殖.
- m6A通路的失调有助于心肌缺血和心脏病发作.
- m6A 分析显示了早期心脏病诊断的潜力.
结论:
- m6A甲基化是CHD背后的复杂过程中的关键参与者.
- m6A 调节器代表了开发新型诊断工具和治疗心血管疾病的治疗干预措施的有希望的目标.
相关概念视频
Spreading of Chromatin Modifications
8.1K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.1K
Phase II Reactions: Methylation Reactions
915
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
915
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495

